000			02079 a2200601 4500
005			20250515100507.0
264		0	_c20080312
008			200803s 0 0 eng d
022			_a1569-8041
024	7		_a10.1093/annonc/mdm511 _2doi
040			_aNLM _beng _cNLM
100	1		_aOverman, M J
245	0	0	_aThe addition of rituximab to CHOP chemotherapy improves overall and failure-free survival for follicular grade 3 lymphoma. _h[electronic resource]
260			_bAnnals of oncology : official journal of the European Society for Medical Oncology _cMar 2008
300			_a553-9 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAntibodies, Monoclonal _xadministration & dosage
650	0	4	_aAntibodies, Monoclonal, Murine-Derived
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage
650	0	4	_aCohort Studies
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDisease-Free Survival
650	0	4	_aDoxorubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aLymphoma, Follicular _xdrug therapy
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aProportional Hazards Models
650	0	4	_aRituximab
650	0	4	_aSalvage Therapy
650	0	4	_aSurvival Rate
650	0	4	_aVincristine _xadministration & dosage
700	1		_aFeng, L
700	1		_aPro, B
700	1		_aMcLaughlin, P
700	1		_aHess, M
700	1		_aSamaniego, F
700	1		_aYounes, A
700	1		_aRomaguera, J E
700	1		_aHagemeister, F B
700	1		_aKwak, L
700	1		_aCabanillas, F
700	1		_aRodriguez, M A
700	1		_aFayad, L E
773	0		_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 19 _gno. 3 _gp. 553-9
856	4	0	_uhttps://doi.org/10.1093/annonc/mdm511 _zAvailable from publisher's website
999			_c17596691 _d17596691